Relmada Therapeutics (RLMD) shares were up nearly 11% in afternoon trading on Friday after the company's Chief Executive Officer Sergio Traversa and Chief Financial Officer Maged Shenouda bought 200,000 shares each, according to separate regulatory filings.
Trading volume stood at over 1.7 million shares against a daily average of about 1.8 million.
Price: 4.52, Change: +0.44, Percent Change: +10.93
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.